AbbVie Inc. officer Perry C Siatias is set to sell 2,919 shares of the company's common stock on February 2, 2024, according to a recent filing. The shares, valued at approximately $496,230, were acquired on the same date through the exercise of stock options, with the issuer being the source of the securities. The transaction involved a cash payment made on the date of acquisition. There have been no other reported sales of securities by Siatias in the past three months, as per the provided documentation.

AbbVie Inc. officer Perry C Siatias is set to sell 2,919 shares of the company's common stock on February 2, 2024, according to a recent filing. The shares, valued at approximately $496,230, were acquired on the same date through the exercise of stock options, with the issuer being the source of the securities. The transaction involved a cash payment made on the date of acquisition. There have been no other reported sales of securities by Siatias in the past three months, as per the provided documentation.